Similar articles for PMID: 375096

Year	Number of Results
1972	1
1975	1
1976	1
1978	2
1979	2
1981	1
1983	1
1985	2
1987	1
1989	2
1992	4
1993	1
1994	2
1995	1
1996	2
1998	2
1999	2
2000	1
2001	3
2003	4
2004	3
2005	3
2006	2
2007	5
2008	3
2009	2
2010	1
2011	1
2012	1
2013	1
2014	4
2015	4
2016	2
2017	3
2018	2
2024	0

1

Systemic candidiasis in mice treated with prednisolone and amphotericin B. 2. Ultrastructure and evidence for fungal toxin.

Blyth W, Stewart GE. Blyth W, et al. Mycopathologia. 1978 Dec 29;66(1-2):51-7. doi: 10.1007/BF00429593. Mycopathologia. 1978. PMID: 375096

2

Systemic candidiasis in mice treated with prednisolone and amphotericin B. 1. Morbidity, mortality and inflammatory reaction.

Blyth W, Stewart GE. Blyth W, et al. Mycopathologia. 1978 Dec 29;66(1-2):41-50. doi: 10.1007/BF00429592. Mycopathologia. 1978. PMID: 375095

3

Antifungal activity of amphotericin B-lipid admixtures in experimental systemic candidosis in naive mice.

Shadkchan Y, Segal E. Shadkchan Y, et al. J Antimicrob Chemother. 1999 Dec;44(6):787-90. doi: 10.1093/jac/44.6.787. J Antimicrob Chemother. 1999. PMID: 10590279

4

Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.

Espuelas MS, Legrand P, Campanero MA, Appel M, Chéron M, Gamazo C, Barratt G, Irache JM. Espuelas MS, et al. J Antimicrob Chemother. 2003 Sep;52(3):419-27. doi: 10.1093/jac/dkg351. Epub 2003 Jul 29. J Antimicrob Chemother. 2003. PMID: 12888593

5

Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.

Espada R, Valdespina S, Molero G, Dea MA, Ballesteros MP, Torrado JJ. Espada R, et al. Int J Antimicrob Agents. 2008 Jul;32(1):55-61. doi: 10.1016/j.ijantimicag.2008.02.025. Epub 2008 Jun 4. Int J Antimicrob Agents. 2008. PMID: 18534826

6

High purity amphotericin B.

Cleary JD, Chapman SW, Swiatlo E, Kramer R. Cleary JD, et al. J Antimicrob Chemother. 2007 Dec;60(6):1331-40. doi: 10.1093/jac/dkm322. Epub 2007 Oct 5. J Antimicrob Chemother. 2007. PMID: 17921178

7

Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.

Kretschmar M, Nichterlein T, Hannak D, Hof H. Kretschmar M, et al. Arzneimittelforschung. 1996 Jul;46(7):711-5. Arzneimittelforschung. 1996. PMID: 8842344

8

[Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy].

Chavanet P, Charlier N, Brenet A, Goux A, Muggéo E, Caillot D, Casasnovas O, Kistermann JP, Waldner A, Portier H. Chavanet P, et al. Pathol Biol (Paris). 1992 May;40(5):507-12. Pathol Biol (Paris). 1992. PMID: 1495835 French.

9

Effects of modified amphotericin in experimental systemic candidiasis.

Shkurupy VA, Selyatitskaya VG, Tsyrendorzhiev DD, Pal'chikova NA, Kurilin VV, Travin MA, Nadeev AP, Troitskii AV. Shkurupy VA, et al. Bull Exp Biol Med. 2007 Apr;143(4):392-4. doi: 10.1007/s10517-007-0138-3. Bull Exp Biol Med. 2007. PMID: 18214282

10

Effects of immunoglobulin G and low-dose amphotericin B on Candida albicans infections in burned mice.

Neely AN, Holder IA. Neely AN, et al. Antimicrob Agents Chemother. 1992 Mar;36(3):643-6. doi: 10.1128/AAC.36.3.643. Antimicrob Agents Chemother. 1992. PMID: 1622177 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

69 results

Results by year